Related Experiment Videos
Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB
1Rigel, Inc. 240 East Grand Ave, South San Francisco, California 94080, USA.
Abstract:
The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5]. To identify proteins associated with the TNF signaling pathway, we performed a yeast two-hybrid interaction screen using RIP as bait. We isolated a kinase, RIP3, which shares homology with the kinase domain of RIP and RIP2 (also known as Rick or CARDIAK). RIP3 could be co-immunoprecipitated with RIP, TRAF2 and TNFR1 in mammalian cells. The carboxy-terminal domain of RIP3, like that of RIP, could activate the transcription factor NFkappaB and induce apoptosis when expressed in mammalian cells. Interestingly, this region shares no significant sequence homology to the death domain of RIP, the caspase-recruiting domain (CARD) of RIP2 [6][7][8] or any other apoptosis-inducing domain. As with RIP and RIP2, the kinase domain of RIP3 was not required for either NFkappaB activation or apoptosis induction. Overexpression of a dominant-negative mutant of RIP3 strongly inhibited the caspase activation but not the NFkappaB activation induced by TNFalpha. Therefore, RIP3 appears to function as an intermediary in TNFalpha-induced apoptosis.
Insights
Researchers identified RIP3, a novel kinase involved in the tumor necrosis factor (TNF) signaling pathway. RIP3 acts as an intermediary in TNF-induced apoptosis, influencing caspase activation but not NF-kappaB activation.
Area of Science:
- Cellular signaling
- Molecular biology
- Immunology
Background:
- Tumor necrosis factor receptor 1 (TNFR1) and Fas receptor initiate signaling cascades via adaptor proteins.
- Understanding TNF signaling pathway components is crucial for deciphering cellular responses.
Purpose of the Study:
- To identify novel proteins interacting with the TNF signaling pathway.
- To characterize the function of a newly identified kinase, RIP3.
Main Methods:
- Yeast two-hybrid interaction screen using RIP as bait.
- Co-immunoprecipitation assays in mammalian cells.
- Functional assays involving NF-kappaB activation and apoptosis induction.
Main Results:
- A novel kinase, RIP3, was identified and shares homology with RIP and RIP2.
- RIP3 interacts with RIP, TRAF2, and TNFR1 in mammalian cells.
- The carboxy-terminal domain of RIP3 activates NF-kappaB and induces apoptosis, independent of its kinase domain.
- Dominant-negative RIP3 mutant inhibits TNFalpha-induced caspase activation but not NF-kappaB activation.
Conclusions:
- RIP3 functions as an intermediary in TNFalpha-induced apoptosis.
- RIP3 plays a role in regulating caspase activation during TNF signaling.